The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock

Sepsis and Septic Shock Clinical Trial

Official title: The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock

Status Completed

Clinical Trial Summary

This study sought to evaluate the association of right ventricular systolic dysfunction and 28-day in-hospital mortality in patients with sepsis and septic shock. Prospective cohort study of adult patients admitted at Burapha university hospital from October 1, 2022 through June 30, 2023 for sepsis and septic shock, who had an echocardiogram within 72 hours after admission for evaluating right ventricular systolic function. Right ventricular systolic dysfunction was defned by the American Society of Echocardiography criteria. Outcomes included 28-day in-hospital mortality, maximal blood lactate, length of intensive care unit(ICU) stay and duration of mechanical ventilation.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Sepsis
• Sepsis and Septic Shock
• Shock
• Shock, Septic
• Systolic Murmurs
• Toxemia

• NCT number: NCT06193109
• Study type: Observational
• Source: Burapha University
• Status: Completed
• Start date: October 1, 2022
• Completion date: July 30, 2023